Literature DB >> 28511463

Unusually High Serum Levels of CA 19-9 in an Ovarian Tumour: Malignant or Benign?

Divya Pandey1, Ritu Sharma2, Shakti Sharma3, Sudha Salhan4.   

Abstract

Carbohydrate antigen 19-9 (CA 19-9) is a tumour marker found to be elevated in some ovarian tumours. We share our experience with a 55-year-old postmenopausal lady with unusually high CA19-9 levels arising from a benign mucinous cystadenoma of the ovary. The levels returned to normal eight weeks following staging laparotomy and a total abdominal hysterectomy with bilateral salpingo-oopherectomy. This report shows rare and significant elevation of CA 19-9 levels with benign mucinous cystadenomas of the ovary thus showing that women with unusually elevated tumour markers may actually harbour benign disease. The tumour markers should not be used to predict the malignant status of a tumour.

Entities:  

Keywords:  Abdominal cavities; Ovarian mucinous cystadenoma; Tumour marker

Year:  2017        PMID: 28511463      PMCID: PMC5427389          DOI: 10.7860/JCDR/2017/21017.9506

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.

Authors:  M J Engelen; H W de Bruijn; H Hollema; K A ten Hoor; P H Willemse; J G Aalders; A G van der Zee
Journal:  Gynecol Oncol       Date:  2000-07       Impact factor: 5.482

2.  Abnormally high level of CA-19-9 in a benign ovarian cyst.

Authors:  Seung-Yeon Pyeon; Ji Young Park; Kyung-Do Ki; Jong-Min Lee
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

3.  Markedly elevated CA19-9 associated with benign ovarian cyst and ascites.

Authors:  Oliver Brain; Laura H W Brown; Shaila Suvarna; Roger Chapman
Journal:  BMJ Case Rep       Date:  2009-03-20

4.  Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.

Authors:  Paul J Kelly; Pooler Archbold; John H Price; Chris Cardwell; W Glenn McCluggage
Journal:  J Clin Pathol       Date:  2010-02       Impact factor: 3.411

5.  CA 19-9 can be a useful tumor marker in ovarian dermoid cysts.

Authors:  A Coskun; G Kiran; O Ozdemir
Journal:  Clin Exp Obstet Gynecol       Date:  2008       Impact factor: 0.146

6.  Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.

Authors:  W M Steinberg; R Gelfand; K K Anderson; J Glenn; S H Kurtzman; W F Sindelar; P P Toskes
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Elevated CA 19-9 levels in mature cystic teratoma of the ovary.

Authors:  Min Sun Kyung; Joong Sub Choi; Seung Hwa Hong; Hak Soon Kim
Journal:  Int J Biol Markers       Date:  2009 Jan-Mar       Impact factor: 3.248

8.  Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.

Authors:  Hye-Yon Cho; Min Sun Kyung
Journal:  Med Sci Monit       Date:  2014-07-30
  8 in total
  2 in total

1.  A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9.

Authors:  Francesk Mulita; Nikoleta Oikonomou; Levan Tchabashvili; Elias Liolis; Ioannis Kehagias
Journal:  Pan Afr Med J       Date:  2020-09-18

Review 2.  Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians.

Authors:  Dimitrios Giannis; Dimitrios Moris; Andrew S Barbas
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.